Trial Profile
Immunogenicity and Tolerability Study of FLUVAL AB Novo Suspension for Injection (trivalent, seasonal influenza vaccine, active ingredient content: 6 μg HA/strain/0.5 ml) for Children and Adolescents
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Apr 2022
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Fluart Innovative Vaccines
- 17 Feb 2021 Status changed from recruiting to completed.
- 22 Oct 2014 New trial record